BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

ECOR

electroCore, Inc.
Nasdaq · Electromedical & electrotherapeutic apparatus (SIC 3845) · FY ends 31 Dec

Revenue, quarterly

$9M+28.0% year on year
$10M$5M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

87.1%+1.5 pp year on year
90%80%70%60%
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$9M+152.0% year on year
$40M$20M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$10M
$5M$0−$5M−$10M
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 6 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty